Explore BRCA2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Introcelluar Protein.
Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
| Target ID |
GM-T15823
|
| Target Name |
BRCA2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
675
|
| Gene ID |
100064578 (Equus caballus), 12190 (Mus musculus), 360254 (Rattus norvegicus), 474180 (Canis lupus familiaris) 493878 (Felis catus), 507069 (Bos taurus), 675 (Homo sapiens), 721981 (Macaca mulatta)
|
| Target Alternative Names |
BRCA2,BRCC2,BROVCA2,Brca2,Breast cancer type 2 susceptibility protein,FACD,FAD,FAD1,FANCD,FANCD1,Fancd1,Fanconi anemia group D1 protein,GLM3,PNCA2,RAB163,XRCC11
|
| Uniprot Accession |
P97929,O35923,Q864S8,P51587
|
| Protein Sub-location |
Introcelluar Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer, Breast Cancer, Ovarian Cancer
|
| Disease from KEGG |
Pathways in cancer, Pancreatic cancer, Breast cancer
|
| Gene Ensembl |
ENSECAG00000014890, ENSMUSG00000041147, ENSCAFG00845015595, ENSBTAG00000000988, ENSG00000139618, ENSMMUG00000007197
|
BRCA2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo675 | Pre-made Human BRCA2/FAD/FACD siRNA oligo Duplex | 675 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo360254 | Pre-made Rat Brca2 siRNA oligo Duplex | 360254 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo12190 | Pre-made Mouse Brca2/Fancd1/RAB163 siRNA oligo Duplex | 12190 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo721981 | Pre-made Cynomolgus/Rhesus macaque BRCA2 siRNA oligo Duplex | 721981 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo493878 | Pre-made Cat/Feline BRCA2 siRNA oligo Duplex | 493878 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo474180 | Pre-made Dog/Canine BRCA2 siRNA oligo Duplex | 474180 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo507069 | Pre-made Bovines/Cattle BRCA2 siRNA oligo Duplex | 507069 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100064578 | Pre-made Equine/Horse BRCA2 siRNA oligo Duplex | 100064578 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
BRCA2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T15823-Ab | Human | Anti-Human BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-rg-T15823-Ab | Rat | Anti-Rat BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-mg-T15823-Ab | Mouse | Anti-Mouse BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T15823-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-felg-T15823-Ab | Cat/Feline | Anti-Cat/Feline BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cang-T15823-Ab | Dog/Canine | Anti-Dog/Canine BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T15823-Ab | Bovines/Cattle | Anti-Bovines/Cattle BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-equg-T15823-Ab | Equine/Horse | Anti-Equine/Horse BRCA2 monoclonal antibody | mab | Therapeutics Target antibody | Detail |
BRCA2 recombinant protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T15823-Ag | Human | Human BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-rg-T15823-Ag | Rat | Rat BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-mg-T15823-Ag | Mouse | Mouse BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cynog-T15823-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-felg-T15823-Ag | Cat/Feline | Cat/Feline BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-cang-T15823-Ag | Dog/Canine | Dog/Canine BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-bovg-T15823-Ag | Bovines/Cattle | Bovines/Cattle BRCA2 recombinant protein | Mammalian cell | Detail |
| GM-Tg-equg-T15823-Ag | Equine/Horse | Equine/Horse BRCA2 recombinant protein | Mammalian cell | Detail |